Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,390.00p on 30-06-2025 at 18:20:05
Change -15.50p -1.1%
Buy 1,394.00p
Sell 1,393.50p
Buy / Sell GSK Shares
Last Trade: Buy 93.00 at 1,390.00p
Day's Volume: 8,873,507
Last Close: 1,390.00p
Open: 1,394.50p
ISIN: GB00BN7SWP63
Day's Range 1,385.00p - 1,405.50p
52wk Range: 1,242.50p - 1,678.00p
Market Capitalisation: £56,247m
VWAP: 1,393.54672p
Shares in Issue: 4,047m

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 93 1,390.00p Ordinary
16:40:52 - 30-Jun-25
Buy* 10 1,390.00p Ordinary
16:40:52 - 30-Jun-25
Buy* 214 1,390.00p Ordinary
16:40:52 - 30-Jun-25
Buy* 11,200 1,390.00p Ordinary
16:40:50 - 30-Jun-25
Buy* 3,411 1,390.00p Ordinary
16:40:50 - 30-Jun-25
Buy* 374 1,390.00p Ordinary
16:40:50 - 30-Jun-25
Buy* 7,849 1,390.00p Ordinary
16:40:50 - 30-Jun-25
Buy* 8 1,390.00p Ordinary
16:40:50 - 30-Jun-25
Buy* 55,595 1,390.00p SI Trade
16:39:30 - 30-Jun-25
Buy* 35,601 1,390.00p SI Trade
16:39:30 - 30-Jun-25
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Jun 2025 (Mon) 1,394.50 1,405.50 1,385.00 1,390.00 8,873,507
27th Jun 2025 (Fri) 1,393.50 1,411.50 1,393.50 1,405.50 4,971,130
26th Jun 2025 (Thu) 1,395.50 1,405.50 1,389.50 1,395.00 12,916,267
25th Jun 2025 (Wed) 1,405.50 1,412.00 1,394.50 1,394.50 6,550,382
24th Jun 2025 (Tue) 1,410.00 1,423.50 1,403.50 1,410.00 13,352,724
23rd Jun 2025 (Mon) 1,401.00 1,415.50 1,398.00 1,403.00 10,649,273
20th Jun 2025 (Fri) 1,440.50 1,445.00 1,400.00 1,402.50 24,023,102
19th Jun 2025 (Thu) 1,432.50 1,441.50 1,424.00 1,435.00 5,123,887
18th Jun 2025 (Wed) 1,464.50 1,470.00 1,443.50 1,449.50 8,648,957
17th Jun 2025 (Tue) 1,482.50 1,485.50 1,465.00 1,480.00 12,362,696
16th Jun 2025 (Mon) 1,498.50 1,506.50 1,485.00 1,485.50 9,116,446
13th Jun 2025 (Fri) 1,536.50 1,554.00 1,509.00 1,511.50 9,549,371
12th Jun 2025 (Thu) 1,525.50 1,557.00 1,523.50 1,549.50 7,395,453
11th Jun 2025 (Wed) 1,516.00 1,528.00 1,508.00 1,523.00 15,815,095
10th Jun 2025 (Tue) 1,500.50 1,512.00 1,492.00 1,508.50 17,136,132
9th Jun 2025 (Mon) 1,512.50 1,516.50 1,503.50 1,509.00 3,845,991
6th Jun 2025 (Fri) 1,509.50 1,521.50 1,504.00 1,513.00 7,336,486
5th Jun 2025 (Thu) 1,500.00 1,513.00 1,492.50 1,512.00 6,135,875
4th Jun 2025 (Wed) 1,483.50 1,501.00 1,476.50 1,494.00 5,213,100
3rd Jun 2025 (Tue) 1,512.50 1,518.50 1,476.00 1,485.00 9,060,705
2nd Jun 2025 (Mon) 1,513.00 1,527.00 1,506.50 1,517.00 9,107,072
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
30th Jun 2025 7:00 am RNS Transaction in Own Shares
27th Jun 2025 7:00 am RNS Transaction in Own Shares
26th Jun 2025 7:00 am RNS Transaction in Own Shares
25th Jun 2025 7:00 am RNS Transaction in Own Shares
24th Jun 2025 3:30 pm RNS Director/PDMR Shareholding
24th Jun 2025 3:00 pm RNS Director Declaration
24th Jun 2025 7:00 am RNS Transaction in Own Shares
23rd Jun 2025 5:50 pm RNS Replacement - Director/PDMR Shareholding
23rd Jun 2025 3:30 pm RNS Director/PDMR Shareholding
23rd Jun 2025 8:30 am RNS Replacement RNS: Linerixibat file accepted by EMA
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON BROKER RATINGS: Babcock International price targets raised

30th Jun 2025 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

GSK drug to treat itch caused by liver disease accepted for EU review

23rd Jun 2025 09:55

(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease. Read More

LONDON MARKET CLOSE: FTSE 100 underperforms Europe despite Iran talks

20th Jun 2025 17:04

(Alliance News) - London's FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and drug stocks offset hopes for progress in the Israel-Iran conflict. Read More

Japan accepts GSK application for expanded use of RSV vaccine Arexvy

20th Jun 2025 08:27

(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [RSV] vaccine Arexvy. Read More

LONDON MARKET CLOSE: FTSE 100 nudges up ahead of Fed after in line CPI

18th Jun 2025 16:53

(Alliance News) - London's FTSE 100 posted modest gains on Wednesday amid ongoing Middle East tensions, as investors weighed broadly in line UK inflation data ahead of rate calls on either side of the pond. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value8,760.96
Change-37.95

Login to your account

Forgot Password?

Not Registered